Robert Gallo

“A Letter from the GVN  Scientific Director and Chair, Scientific Leadership Board”
Robert C. Gallo, MD

The concept of a Global Virus Network (GVN) began back in the 1980’s when a small group of medical virologists realized that virtually no working virologists had a global directive for researching the cause of AIDS during the earliest years of the epidemic. Conversely, important groups such as the World Health Organization which did have a global mandate for combatting the new disease had virtually no resident expertise in the kind of virus that was subsequently shown to be the cause of AIDS, namely, a retrovirus. Examining the history of other great epidemics of the 20th century, Influenza and Polio, reveals similar disconnects between available expertise and the urgent public need to identify causation and prevention modes.

GVN Centers, with strong working relationships among them, are poised to engage in any outbreak situation by providing the world’s only network of top basic medical virologists from around the globe covering all classes of human viral threats. GVN is also committed to training the next generation of medical virologists in order to meet the critical need posed by the graying of members of our own discipline, and to inform and educate policymakers and members of the public about the role of medical virologists in mitigating viral illness and preventing infections from taking hold in populations. This is especially important as my colleagues and I have noticed a significant decline in medical students entering the field of medical virology.

Scientific Advisory Board

Luigi Chieco-Bianchi, MD, PhD
University of Padua, Italy

Barry Beaty, PhD
Colorado State University, US

Arsène Burny, PhD
Gembloux Agro-Biotech, Belgium

Franco Buonaguro, MD.
Istituto Nazionale Tumori “Fondazione Pascale” National Cancer Institute, Italy

Xiao-Ping Dong
China CDC, China

John Glass, PhD
J. Craig Venter Institute
Maryland, USA

Glenda Gray, MBBCh, FCPAED
President, Medical Research Council of South Africa

Diane Griffin, MD,PhD
Johns Hopkins University

Volker Erfle, DVM, PhD
 TU München Institut für Molekulare Virologie, Germany.

José Esparza, PhD
Past President, GVN

William Hall, MD, PhD
Professor of Medical Microbiology

HHideki Hasegawa
Hideki Hasegawa, MD,PhD
National Institute of Infectious Diseases

James LeDuc, PhD
University of Texas Medical BranchGalveston National Labs

Michael Oldstone, M.D.
The Scripps Research Institute, USA

Alexey Mazus, MD
Moscow Center for AIDS Prevention

James McCluskey, MD
Doherty Institute

Peter Palese, PhD
Professor and Chair, Microbiology
Mt. Sinai School of Medicine

Massimo Palmarini, DVM PhD FRSE
Medical Research Council Glasgow, UK

Janusz Paweska, DVSc
South African NHLS

Ulrike Protzer

Ulrike Protzer, MD.
Institute of Virology TU Munich, Germany

Victor Romanowski, PhD
National University of La Plata

Erica Ollman Saphire, PhD.
The Scripps Research Institute, USA

Andres Vahlne, MD
Karolinska Institutet

Yi Zeng, MD
China Centers for Disease Control